VistaGen Therapeutics's Stock Price And Volume Action
VistaGen Therapeutics's VTGN stock is trading up 7.9% to a price of $2.33. Thursday the stock has been traded at a volume of 762.60 thousand, about 16.32% of its recent 30-day volume average of 4.67 million.
Why It's Moving
Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: VistaGen Therapeutics shares are trading higher after the company announced its PH10 nasal spray showed a different mechanism of action from benzodiazepines in a preclinical study.
Further Analysis of Recent Price Action
The stock's 50-day moving average was $2.18 at the time this article was published. Over the past fifty-two weeks, the price has risen as high as $3.18 and fallen to a low of $0.3.
If you're looking for timely and concise explanations of why a stock is moving, check out Benzinga Pro. Subscribers get ‘Why Is It Moving' alerts as soon as our research team identifies the cause of the price action in a stock. Click here to learn more.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.